IPC’s International Fellowship program provides young dermatologists and researchers interested in psoriasis full access to the knowledge of our network of experts and represents our commitment to cultivating expertise in the field.
Meet the 2019 Fellows
Meet the 2018 Fellows
The 2020 IPC International Fellowship Program is supported by AbbVie.
Awarded fellows are matched with IPC Board Members or Councilors to observe and participate in clinical practice and laboratory research of patients with psoriasis. This opportunity provides real-world practice in the investigation, diagnosis, and development of treatment plans for psoriasis. In addition, the program provides an opportunity for IPC Fellows to develop ongoing relationships with key opinion leaders by participating in IPC programs and activities throughout a one-year period.
ADDITIONAL INFORMATION AND HOW TO APPLY
Julia-Tatjana Maul, MD University Hospital of Zurich | Zürich, Switzerland
Julia-Tatjana Maul, MD, is a board qualified Senior Dermatologist in the Clinic for Dermatology at the University Hospital of Zürich, Switzerland. Dr. Maul contributed to the initiation and is now the principal investigator of the Swiss Dermatology Network for Targeted Therapy (SDNTT) in Psoriasis of Zürich and has contributed to the Global Psoriasis Atlas (GPA) through a 3-month study of psoriasis epidemiology and access to healthcare for psoriasis patients in South America. In October 2019, Dr. Maul officially joined the GPA team as a medical coordinator. During her fellowship, Dr. Maul will collaborate with Claudia de la Cruz of Clinica Dermacross in Chile and Ricardo Romiti of the University of Sao Paulo in Brazil.
JAQUELINI BARBOZA DA SILVA, MD SANTA CRUZ UNIVERSITY | SANTA CRUZ DO SUL, BRAZIL
Jaquelini Barboza da Silva, MD is a dermatologist in private practice in Santa Cruz do Sul, Brazil. Additionally, Dr. Barboza da Silva is an instructor at Santa Cruz University, where she is completing a master’s degree studying biomarkers in psoriasis by spectroscopy. She is a blind investigator in a rizankizumab clinical trial at Moinhos de Vento research center. Dr. Barboza da Silva has scientific interests in biomarkers and the burden of psoriasis. Her key clinical interest is to provide the best treatment for each patient profile. She will study with Darren Ashcroft and Chris Griffiths of University of Manchester in the United Kingdom and attend the European Academy of Dermatology and Venereology (EADV) meeting.
ALVARO GONZALES-CANTERO, MD, PHD HOSPITAL RAMÓN Y CAJAL | MADRID, SPAIN
Alvaro González-Cantero, MD, PhD, works as a dermatologist at the Department of Dermatology of the Ramón y Cajal University Hospital in Madrid, Spain, where he combines patient care with research. He received his PhD in psoriasis and comorbidities in 2019 at the University of Castilla la Mancha. He has special interest in increasing the knowledge of the relationship between psoriasis and atherosclerosis. He is the principal investigator for a cohort study to investigate the pathophysiological mechanisms underlying cardiovascular comorbidity in psoriasis. His research on cardiovascular comorbidities and systemic inflammation in psoriasis has been published in the Journal of the American Academy of Dermatology and Plos One and his presentations on the topic have received excellency awards on several occasions in different scientific meetings. Dr. González-Cantero will study with Joel Gelfand of the University of Pennsylvania in the United States and attend the European Academy of Dermatology and Venereology (EADV) meeting.
LILY TUMALAD, MD, FPDS RIZAL MEDICAL CENTER | PARANAQUE, PHILIPPINES
Lily Tumalad, MD, FPDS is a dermatologist with special interest in psoriasis and photodermatology. She is a consultant in two government training institutions in Manila, Philippines. She is currently head of the psoriasis center of the Department of Dermatology at Rizal Medical Center, as well as head of the phototherapy unit of the Department of Dermatology at East Avenue Medical Center. Her work is a combination of clinical practice, teaching residents, conducting lectures, and research. She was the lead consultant of the technical working group for developing the clinical pathway for psoriasis at Rizal Medical Center. Dr. Tumalad completed her dermatology residency at the University of the Philippines-Philippine General Hospital and did a photodermatology fellowship at the National Skin Centre in Singapore. She will study with Curdin Conrad of Lausanne University Hospital in Switzerland and attend the European Academy of Dermatology and Venereology (EADV) meeting.
MATTHEW VESELY, MD, PHD YALE SCHOOL OF MEDICINE | NEW HAVEN, CONNECTICUT, USA
Matthew Vesely, MD, PhD, is an Instructor in the Department of Dermatology at Yale University where he combines patient care with translational research in autoimmune skin diseases. Dr. Vesely obtained his PhD in immunology studying how the immune system detects and eradicates cancers. Since completing his dermatology residency in 2017, his clinical interests are centered on caring for patients with inflammatory and autoimmune skin diseases. His translational research program focuses on identifying immune inhibitory receptors to better understand the pathogenesis of chronic autoimmune skin diseases such as psoriasis. Ultimately, he hopes to develop novel therapies for these debilitating disorders by modulating T cell activation states. Dr. Vesely will study with Alice Gottlieb of the Icahn School of Medicine at Mt. Sinai in the United States and attend the American Academy of Dermatology Annual Meeting (AAD).
More information.